Oligometastatic prostate cancer (omPCa) represents an intermediate stage of cancer dissemination between localized and widely metastatic disease. With dramatic improvements in staging—particularly through advanced functional imaging such as PSMA-PET and robotic-assisted (RA) targeted biopsies (RA-TB)—omPCa is now more frequently detected, both at primary diagnosis and in oligorecurrent disease (Patel et al., 2020). Singh et al.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Ryan
Contact Ryan, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack